News & Updates

Empagliflozin advancing on all fronts: Readying for the future with EMPEROR

11 Aug 2020

In this final issue of our series, join us as we look into the upcoming results of the pivotal EMPEROR trials, which will investigate the use of empagliflozin in patients with either preserved or reduced ejection fraction heart failure, with or without type 2 diabetes. Understand why heart failure has such a high clinical burden, and the great unmet need in providing solutions for it.

Empagliflozin advancing on all fronts: Readying for the future with EMPEROR

11 Aug 2020

DOACs a safe, effective alternative to warfarin in NVAF patients with hyperthyroidism

11 Aug 2020

Use of direct oral anticoagulants (DOACs) appears to be safe and effective among nonvalvular atrial fibrillation (NVAF) patients with concomitant hyperthyroidism, according to a recent study, noting the potential of DOACs as an alternative to warfarin in these individuals.

DOACs a safe, effective alternative to warfarin in NVAF patients with hyperthyroidism

11 Aug 2020

Pleasure from drinking milkshake does not cause obesity

10 Aug 2020

The experience of enhanced pleasure during the consumption of delicious energy-dense foods, such as milkshakes, does not necessarily promote overeating and contribute to obesity, according to a study.

Pleasure from drinking milkshake does not cause obesity

10 Aug 2020

How does diabetes influence CVD risk in men vs women?

08 Aug 2020

Women who develop diabetes show less favourable changes in cardiovascular disease (CVD) risk factors, such that blood pressure and lipid levels deteriorate rapidly compared with their male counterparts, a study has found.

How does diabetes influence CVD risk in men vs women?

08 Aug 2020

Hypertension common among kids with diabetic ketoacidosis

08 Aug 2020

Hypertension is a common phenomenon in children with diabetic ketoacidosis (DKA), a study has found.

Hypertension common among kids with diabetic ketoacidosis

08 Aug 2020

VERTIS CV highlights CV safety of ertugliflozin in T2D

07 Aug 2020 by

Patients with type 2 diabetes (T2D) and established atherosclerotic cardiovascular disease (ASCVD) do not have a higher risk of major adverse cardiovascular events (MACE) with ertugliflozin, according to results of the phase III VERTIS CV* trial.

VERTIS CV highlights CV safety of ertugliflozin in T2D

07 Aug 2020

SGLT-2 inhibitors may induce diabetic ketoacidosis

06 Aug 2020

Sodium–glucose cotransporter-2 (SGLT-2) inhibitors increase the risk for diabetic ketoacidosis (DKA) by almost threefold, with molecule-specific analyses suggesting a class effect, according to a study.

SGLT-2 inhibitors may induce diabetic ketoacidosis

06 Aug 2020

Bedtime glucose, next-day fasting glucose may be indicators of hypoglycaemia in T1D

05 Aug 2020

Low levels of glucose at bedtime of the previous day and fasting glucose appear to be reasonably predictive of nocturnal asymptomatic, serious, clinically important hypoglycaemia in type 1 diabetes (T1D) patients taking insulin degludec (IDeg), a new study has found.

Bedtime glucose, next-day fasting glucose may be indicators of hypoglycaemia in T1D

05 Aug 2020

Bariatric revision will do the job for patients with persistent obesity-related conditions

05 Aug 2020 by

Patients who have undergone weight-loss surgery may sometimes have to return for revision, which helps improve outcomes associated with obesity, such as diabetes and hypertension, according to a meta-analysis.

Bariatric revision will do the job for patients with persistent obesity-related conditions

05 Aug 2020

Maternal, paternal diabetes histories confer different degrees of risk to offspring

04 Aug 2020

Maternal and paternal histories of diabetes have different effects on offspring risk of insulin secretion and resistance, and diabetes, a new study has found.

Maternal, paternal diabetes histories confer different degrees of risk to offspring

04 Aug 2020

News & Updates

Filter by Specialty:

Specialty:

Empagliflozin advancing on all fronts: Readying for the future with EMPEROR

Empagliflozin advancing on all fronts: Readying for the future with EMPEROR

DOACs a safe, effective alternative to warfarin in NVAF patients with hyperthyroidism

DOACs a safe, effective alternative to warfarin in NVAF patients with hyperthyroidism

Pleasure from drinking milkshake does not cause obesity

Pleasure from drinking milkshake does not cause obesity

How does diabetes influence CVD risk in men vs women?

How does diabetes influence CVD risk in men vs women?

Hypertension common among kids with diabetic ketoacidosis

Hypertension common among kids with diabetic ketoacidosis

VERTIS CV highlights CV safety of ertugliflozin in T2D

VERTIS CV highlights CV safety of ertugliflozin in T2D

SGLT-2 inhibitors may induce diabetic ketoacidosis

SGLT-2 inhibitors may induce diabetic ketoacidosis

Bedtime glucose, next-day fasting glucose may be indicators of hypoglycaemia in T1D

Bedtime glucose, next-day fasting glucose may be indicators of hypoglycaemia in T1D

Bariatric revision will do the job for patients with persistent obesity-related conditions

Bariatric revision will do the job for patients with persistent obesity-related conditions

Maternal, paternal diabetes histories confer different degrees of risk to offspring

Maternal, paternal diabetes histories confer different degrees of risk to offspring